Literature DB >> 25971995

The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature.

Giovanni Cammaroto1, Natale Quartuccio2, Alessandro Sindoni2, Francesca Di Mauro2, Federico Caobelli3.   

Abstract

The management of head and neck tumor (HNSCC) has been changing over the years, especially due to the aid of imaging techniques that help physicians to attain a correct diagnosis. These techniques represent a valuable tool to help tailor treatment and during follow-up of patients affected by malignancies. The aim of this review is to summarize the results of the most recent and relevant studies about the use of PET imaging in HNSCCs. This review is divided into six chapters: (1) The role of PET/CT in the pre-treatment phase; (2) PET/CT and radiotherapy planning; (3) PET/CT in the post-treatment setting; (4) PET/CT and SUVmax for prediction of prognosis; (5) miscellanea on the utility of PET in specific HNSCCs; (6) non-FDG PET tracers used in HNSCC. Promising results have been obtained so far. Despite the encouraging outcomes, more investigations are needed to warrant the value of this technique, especially in the pre-treatment setting.

Entities:  

Keywords:  Chemotherapy; Head and neck carcinomas; PET/CT; Patient management; Radiotherapy

Mesh:

Year:  2015        PMID: 25971995     DOI: 10.1007/s00405-015-3651-4

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  142 in total

1.  [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas.

Authors:  E van der Harst; W W de Herder ; H A Bruining; H J Bonjer; R R de Krijger ; S W Lamberts; A H van de Meiracker ; F Boomsma; T Stijnen; E P Krenning; F T Bosman; D J Kwekkeboom
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

2.  The use of multiple time point dynamic positron emission tomography/computed tomography in patients with oral/head and neck cancer does not predictably identify metastatic cervical lymph nodes.

Authors:  Eric R Carlson; Josh Schaefferkoetter; David Townsend; J Michael McCoy; Paul D Campbell; Misty Long
Journal:  J Oral Maxillofac Surg       Date:  2012-06-26       Impact factor: 1.895

3.  The role of positron emission tomography/CT imaging in head and neck cancer patients after radical chemoradiotherapy.

Authors:  J M Sherriff; B Ogunremi; S Colley; P Sanghera; A Hartley
Journal:  Br J Radiol       Date:  2012-06-27       Impact factor: 3.039

4.  18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.

Authors:  Heiko Schöder; Diane L Carlson; Dennis H Kraus; Hilda E Stambuk; Mithat Gönen; Yusuf E Erdi; Henry W D Yeung; Andrew G Huvos; Jatin P Shah; Steven M Larson; Richard J Wong
Journal:  J Nucl Med       Date:  2006-05       Impact factor: 10.057

5.  Utility of 18F-FDG PET/CT for detecting neck metastasis in patients with salivary gland carcinomas: preoperative planning for necessity and extent of neck dissection.

Authors:  Min-Joo Kim; Jae Seung Kim; Jong-Lyel Roh; Jeong Hyun Lee; Kyung-Ja Cho; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  Ann Surg Oncol       Date:  2012-11-19       Impact factor: 5.344

6.  Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.

Authors:  Trang H La; Edith J Filion; Brit B Turnbull; Jackie N Chu; Percy Lee; Khoa Nguyen; Peter Maxim; Andy Quon; Edward E Graves; Billy W Loo; Quynh-Thu Le
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-14       Impact factor: 7.038

7.  18F-FLT PET during radiotherapy or chemoradiotherapy in head and neck squamous cell carcinoma is an early predictor of outcome.

Authors:  Bianca A W Hoeben; Esther G C Troost; Paul N Span; Carla M L van Herpen; Johan Bussink; Wim J G Oyen; Johannes H A M Kaanders
Journal:  J Nucl Med       Date:  2013-01-23       Impact factor: 10.057

8.  PET changes management and improves prognostic stratification in patients with head and neck cancer: results of a multicenter prospective study.

Authors:  Andrew M Scott; Dishan H Gunawardana; Dylan Bartholomeusz; Jayne E Ramshaw; Peter Lin
Journal:  J Nucl Med       Date:  2008-09-15       Impact factor: 10.057

9.  Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer.

Authors:  Yutaka Yamazaki; Masaaki Saitoh; Ken-ichi Notani; Kanchu Tei; Yasunori Totsuka; Shu-ichi Takinami; Kakuko Kanegae; Masayuki Inubushi; Nagara Tamaki; Yoshimasa Kitagawa
Journal:  Ann Nucl Med       Date:  2008-05-23       Impact factor: 2.668

10.  Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma.

Authors:  P Xie; J-B Yue; Z Fu; R Feng; J-M Yu
Journal:  Ann Oncol       Date:  2009-11-13       Impact factor: 32.976

View more
  6 in total

1.  Preoperative 18F-FDG-PET/CT vs Contrast-Enhanced CT to Identify Regional Nodal Metastasis among Patients with Head and Neck Squamous Cell Carcinoma.

Authors:  Joshua K Cho; Thomas J Ow; Andrew Y Lee; Richard V Smith; Nicolas F Schlecht; Bradley A Schiff; Andrew B Tassler; Juan Lin; Renee M Moadel; Ana Valdivia; Tony Abraham; Edwin Gulko; Matthew Neimark; Berrin Ustun; Jacqueline A Bello; Keivan Shifteh
Journal:  Otolaryngol Head Neck Surg       Date:  2017-06-13       Impact factor: 3.497

2.  Recurrent oropharyngeal cancer after organ preserving treatment: pattern of failure and survival.

Authors:  M de Ridder; Z A R Gouw; J J Sonke; A Navran; B Jasperse; J Heukelom; M E T Tesselaar; W M C Klop; M W M van den Brekel; Abrahim Al-Mamgani
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-09       Impact factor: 2.503

3.  Impact of 3T multiparametric MRI and FDG-PET-CT in the evaluation of occult primary cancer with cervical node metastasis.

Authors:  Mária Gődény; Zsolt Lengyel; Gábor Polony; Zoltán Takácsi Nagy; Gergely Léránt; Orsolya Zámbó; Éva Remenár; László Tamás; Miklós Kásler
Journal:  Cancer Imaging       Date:  2016-11-04       Impact factor: 3.909

4.  Early metabolic 18F-FDG PET/CT response of locally advanced squamous-cell carcinoma of head and neck to induction chemotherapy: A prospective pilot study.

Authors:  Ulisses Ribaldo Nicolau; Victor Hugo Fonseca de Jesus; Eduardo Nóbrega Pereira Lima; Marclesson Santos Alves; Thiago Bueno de Oliveira; Louise De Brot Andrade; Virgilio Souza Silva; Paula Cacciatore Bes; Tadeu Ferreira de Paiva; Vinicius Fernando Calsavara; Andrea Paiva Gadelha Guimarães; Loureno Cezana; Paula Nicole Vieira Pinto Barbosa; Gislaine Cristina Lopes Machado Porto; Antônio Cássio Assis Pellizzon; Genival Barbosa de Carvalho; Luiz Paulo Kowalski
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

5.  Identification of a metabolic reprogramming-related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis.

Authors:  Weijie Qiang; Yifei Dai; Xiaoyan Xing; Xiaobo Sun
Journal:  Cancer Med       Date:  2022-03-18       Impact factor: 4.711

Review 6.  Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer.

Authors:  Hyung Kwon Byeon; Jaemoon Yang; Minhee Ku
Journal:  Exp Mol Med       Date:  2019-01-16       Impact factor: 8.718

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.